BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Atwa SM, Handoussa H, Hosny KM, Odenthal M, El Tayebi HM. Pivotal role of long non-coding ribonucleic acid-X-inactive specific transcript in regulating immune checkpoint programmed death ligand 1 through a shared pathway between miR-194-5p and miR-155-5p in hepatocellular carcinoma. World J Hepatol 2020; 12(12): 1211-1227 [PMID: 33442449 DOI: 10.4254/wjh.v12.i12.1211]
URL: https://www.wjgnet.com/1948-5182/full/v12/i12/1211.htm
Number Citing Articles
1
Jakub Litak, Wiesława Grajkowska, Jacek Bogucki, Paweł Kowalczyk, Alicja Petniak, Arkadiusz Podkowiński, Justyna Szumiło, Janusz Kocki, Jacek Roliński, Mansur Rahnama-Hezavah, Marcin Roszkowski, Cezary Grochowski. PD-L1/miR-155 Interplay in Pediatric High-Grade GliomaBrain Sciences 2022; 12(3): 324 doi: 10.3390/brainsci12030324
2
Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targetsProgress in Biophysics and Molecular Biology 2023; 177: 207 doi: 10.1016/j.pbiomolbio.2022.12.004
3
Mai A. Abd-Elmawla, Yumn A. Elsabagh, Nora M. Aborehab. Association of XIST/miRNA155/Gab2/TAK1 cascade with the pathogenesis of anti-phospholipid syndrome and its effect on cell adhesion molecules and inflammatory mediatorsScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-45214-z
4
Wenxiao Jiang, Shuya Pan, Xin Chen, Zhi-wei Wang, Xueqiong Zhu. The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapyMolecular Cancer 2021; 20(1) doi: 10.1186/s12943-021-01406-7
5
Chengzhi Wang, Xin Li, Lijuan Zhang, Ying Chen, Ruijie Dong, Jieyou Zhang, Jingyi Zhao, Xiangdong Guo, Guangze Yang, Yan Li, Chao Gu, Qing Xi, Rongxin Zhang. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancerInternational Immunopharmacology 2021; 97: 107822 doi: 10.1016/j.intimp.2021.107822
6
Radwa Y. Mekky, Mai F. Ragab, Tamer Manie, Abdelrahman A. Attia, Rana A. Youness. MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancerTranslational Oncology 2023; 31: 101653 doi: 10.1016/j.tranon.2023.101653
7
Sepideh Maralbashi, Cynthia Aslan, Houman Kahroba, Milad Asadi, Mohammad Sadegh Soltani-Zangbar, Navideh Haghnavaz, Farhad Jadidi, Farhad Salari, Tohid Kazemi. Docosahexaenoic acid (DHA) impairs hypoxia-induced cellular and exosomal overexpression of immune-checkpoints and immunomodulatory molecules in different subtypes of breast cancer cellsBMC Nutrition 2024; 10(1) doi: 10.1186/s40795-024-00844-y
8
Chen Xue, Xinyu Gu, Zhengyi Bao, Yuanshuai Su, Juan Lu, Lanjuan Li. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor MicroenvironmentFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.847728
9
José Luis García-Giménez, Wiam Saadi, Angel L. Ortega, Agustin Lahoz, Guillermo Suay, Julián Carretero, Javier Pereda, Ahlam Fatmi, Federico V. Pallardó, Salvador Mena-Molla. miRNAs Related to Immune Checkpoint Inhibitor Response: A Systematic ReviewInternational Journal of Molecular Sciences 2024; 25(3): 1737 doi: 10.3390/ijms25031737
10
Lei Wang, Qiu‐Mei Cao. Long non‐coding RNA XIST alleviates sepsis‐induced acute kidney injury through inhibiting inflammation and cell apoptosis via regulating miR‐155‐5p/WWC1 axisThe Kaohsiung Journal of Medical Sciences 2022; 38(1): 6 doi: 10.1002/kjm2.12442
11
Andrea del Saz-Lara, María-Carmen López de las Hazas, Francesco Visioli, Alberto Dávalos. Nutri-Epigenetic Effects of Phenolic Compounds from Extra Virgin Olive Oil: A Systematic ReviewAdvances in Nutrition 2022; 13(5): 2039 doi: 10.1093/advances/nmac067
12
Liyuan Hao, Shenghao Li, Jiali Deng, Na Li, Fei Yu, Zhi Jiang, Junli Zhang, Xinli Shi, Xiaoyu Hu. The current status and future of PD-L1 in liver cancerFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1323581